It’s common for scalable companies with good business models to involve addiction.
I mean addiction in a broad sense. This includes addiction to both physical products and digital goods and services. Addiction is a retention metric.
And retention (how long someone stays a paid customer or user) is what fuels many businesses. Let’s look at this with opioid addiction, focusing on Purdue Pharma’s product OxyContin. What second-order effects drive the opioid crisis?
Continue reading “The Opioid Crisis (and addiction-based business models)”